Retroperitoneal leiomyosarcoma is a rare but aggressive soft tissue sarcoma originating from smooth muscle cells. It accounts for approximately 25-30% of retroperitoneal sarcomas. Most commonly arises from the wall of the inferior vena cava (IVC) or retroperitoneal venous structures; less commonly from retroperitoneal smooth muscle (ureter, gonadal vessels). Presents as a large, heterogeneous, necrotic mass, usually >10 cm at diagnosis. Three growth patterns are described for IVC-origin tumors: intraluminal, extraluminal, and mixed. Surgical resection is the primary treatment, though R0 resection may be challenging due to anatomic proximity (great vessels, kidneys, pancreas). Local recurrence rates are high (40-60%) and hematogenous metastasis (lung, liver) is common. Five-year survival is approximately 40-60%.
Age Range
40-75
Peak Age
55
Gender
Female predominant
Prevalence
Uncommon
Retroperitoneal leiomyosarcoma develops from malignant transformation of smooth muscle cells. In IVC-origin tumors, smooth muscle cells in the tunica media undergo neoplastic proliferation with intraluminal or extraluminal growth. Rapid tumor growth leads to insufficient blood supply centrally, causing coagulative necrosis — reflected on CT as heterogeneous enhancement and central hypodensity. Necrotic areas may liquefy creating cystic degeneration — appearing as T2 hyperintense areas on MRI. Neovasculature in tumor stroma creates peripheral arterial enhancement, while fibrous and cellular solid components show delayed enhancement. IVC intraluminal growth may cause venous obstruction leading to lower extremity edema, renal vein congestion, and Budd-Chiari syndrome. Hematogenous spread occurs primarily to lungs and liver via venous drainage.
Enhancing soft tissue density filling defect within IVC lumen — pathognomonic finding of leiomyosarcoma originating from IVC wall with intraluminal growth. This is the most important distinguishing criterion from other retroperitoneal sarcomas.
Large (usually >10 cm) lobulated mass with heterogeneous density in the retroperitoneum. Solid components are soft tissue density (40-60 HU) with central necrotic areas of low density (10-25 HU). Mass displaces adjacent organs (kidney, pancreas, bowel) anteriorly and laterally. Shows peripheral and heterogeneous enhancement on contrast-enhanced phases — contrast between viable solid tissue and necrotic areas is prominent.
Report Sentence
A lobulated, heterogeneously enhancing mass measuring approximately ... cm is observed in the retroperitoneum with internal areas of necrosis, consistent with retroperitoneal sarcoma (leiomyosarcoma).
Intraluminal tumor extension visible as filling defect within IVC lumen. Tumor thrombus shows soft tissue density enhancement — critical for distinguishing from bland thrombus. Partial or complete obliteration of IVC lumen may be seen. Extension to renal vein and hepatic vein level is critical for surgical planning. Suprarenal IVC involvement indicates worse prognosis.
Report Sentence
An enhancing soft tissue density filling defect is observed within the inferior vena cava lumen, consistent with tumor thrombus; suggesting intraluminal extension of leiomyosarcoma.
Mass shows heterogeneous signal on T2-weighted sequences. Solid cellular areas show intermediate T2 intensity (isointense to mildly hyperintense), while necrotic and cystic degeneration areas show markedly T2 hyperintense signal. Hemorrhagic foci are T1 hyperintense. Hemorrhagic necrosis is characterized by mixed T1 and T2 signal. Tumor periphery often shows well-defined pseudocapsule, but margins become irregular at areas of local invasion.
Report Sentence
Retroperitoneal mass shows heterogeneous signal on T2-weighted sequences with markedly hyperintense necrotic areas and intermediate intensity solid components, consistent with leiomyosarcoma.
Diffusion-weighted imaging (DWI) shows restricted diffusion in solid cellular components — hyperintense signal at high b-value (b=800-1000) and low ADC values. Necrotic areas do not show restriction — T2 shine-through may appear hyperintense on DWI but distinguished by high ADC values. Degree of diffusion restriction correlates with tumor grade and cellularity.
Report Sentence
Restricted diffusion on DWI with low ADC values is observed in the solid components of the mass, suggesting high cellularity.
Retroperitoneal mass displaces adjacent great vessels (aorta, IVC, renal arteries, iliac vessels) but generally does not encase them — this feature is a key differentiator from retroperitoneal fibrosis. Kidneys are displaced inferolaterally, pancreas anterosuperiorly, bowel loops anteriorly. Progressive enhancement in solid components may be seen on delayed phase — fibrous stroma continues contrast retention.
Report Sentence
Mass displaces retroperitoneal great vessels without encasement, showing a growth pattern consistent with retroperitoneal sarcoma.
PET-CT shows high FDG uptake in leiomyosarcoma — SUVmax usually >5-8. Uptake is heterogeneous with intense activity in viable solid tissue and low/absent in necrotic areas. FDG uptake correlates with tumor grade — higher uptake in high-grade tumors. Change in SUVmax is an early biomarker for treatment response. High sensitivity for distant metastasis detection (lung, liver, bone).
Report Sentence
Heterogeneous intense FDG uptake (SUVmax: ...) is observed in the retroperitoneal mass on PET-CT, consistent with high-grade sarcoma.
US shows a large mass of mixed echogenicity (solid + cystic areas) in the retroperitoneum. Solid components are typically hypoechoic or heterogeneous. Necrotic areas are anechoic or contain low-level internal echoes. Doppler US shows internal vascularity in solid areas — irregularly distributed arterial and venous flow. IVC intraluminal growth shows solid echogenicity and flow loss within IVC lumen.
Report Sentence
A large mass of mixed echogenicity with internal vascularity is observed in the retroperitoneum; further evaluation with CT/MRI is recommended.
Criteria
Tumor grows predominantly within IVC lumen; minimal extraluminal component
Distinct Features
Solid mass within IVC lumen, risk of Budd-Chiari syndrome, lower extremity edema; surgery may require IVC reconstruction/graft
Criteria
Tumor grows predominantly outside IVC (retroperitoneal space); minimal or no intraluminal component
Distinct Features
Large retroperitoneal mass originating from IVC but growing outward; displaces adjacent organs; IVC connection demonstrable on CT
Criteria
Both intraluminal and extraluminal significant components; most common type
Distinct Features
Filling defect in IVC + large exophytic mass in retroperitoneum; most challenging surgical type — IVC resection + retroperitoneal dissection
Criteria
Arising from gonadal vein, renal vein, ureteral smooth muscle, or retroperitoneal connective tissue
Distinct Features
Retroperitoneal mass without direct IVC relationship; source vessel usually identifiable on CT/MR; rare — <20% of all retroperitoneal leiomyosarcomas
Distinguishing Feature
Liposarcoma contains macroscopic fat density regions (-30 to -120 HU); leiomyosarcoma has no fat density and appears more homogeneously solid
Distinguishing Feature
RPF shows homogeneous plaque encasing aorta with preserved lumen and medial ureteral deviation; leiomyosarcoma shows large heterogeneous mass displacing rather than encasing vessels
Distinguishing Feature
Schwannoma shows characteristic target sign (central low, peripheral high T2 signal); schwannoma grows more slowly, is well-circumscribed, and lacks direct IVC relationship
Distinguishing Feature
Paraganglioma shows markedly hypervascular enhancement (salt-and-pepper appearance) and functional catecholamine secretion; leiomyosarcoma has more heterogeneous enhancement with predominant necrosis
Distinguishing Feature
Retroperitoneal hematoma shows high density (60-80 HU) in acute phase, no enhancement, and trauma/anticoagulant history; leiomyosarcoma has enhancing solid mass with necrosis — chronic progressive mass effect
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
3-monthRetroperitoneal leiomyosarcoma is an aggressive tumor requiring early surgical planning. Core biopsy for histopathological confirmation and MDT evaluation are essential. Surgical resection (R0 goal) is primary treatment — vascular surgery may be needed for IVC involvement. Neoadjuvant chemo/radiotherapy in selected patients. Post-operative follow-up with CT/MRI every 3 months for recurrence and metastasis — highest risk in first 2 years.
Retroperitoneal leiomyosarcoma is an aggressive tumor with generally poor prognosis. Surgical resection is the primary treatment but IVC involvement complicates surgery. Liver and lung metastases are common. Chemotherapy response is limited. Vascular reconstruction may be needed for IVC-origin tumors.